We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Novel Platform Detects Coronavirus Particles with “Slow Light”

By LabMedica International staff writers
Posted on 22 Apr 2022

Existing methods for detecting and diagnosing COVID-19 are either expensive and complex or inaccurate. More...

Now, scientists have developed a novel biosensing platform to detect and quantify viral particles using a simple optical microscope and antibody proteins. Their versatile approach, based on slowing down light, could pave the way to new diagnostic tools and next-generation detection platforms that are fast, accurate, and low-cost.

Scientists at the Gwangju Institute of Science and Technology (GIST, Gwangju, Korea) have developed a new technique to easily visualize viruses using an optical microscope. A key element of their detection platform, called the Gires-Tournois immunoassay platform (GTIP), is the Gires-Tournois "resonance structure," a film made from three stacked layers of specific materials that produce a peculiar optical phenomenon called "slow light." Because of how incident light rebounds inside the resonant layers before being reflected, the color of the platform seen through an optical microscope appears very uniform. However, nanometer-sized virus particles affect the resonance frequency of GTIP in their immediate vicinity by slowing down the light that gets reflected around them. The "slow light" manifests as a vivid color change in the reflected light so that, when viewed through the microscope, the virus particle clusters look like "islands" of a different color compared to the background.

To ensure that their system only detects coronavirus particles, the researchers coated the top layer of GTIP with antibody proteins specific to SARS-CoV-2. Interestingly, not only did the system enable the detection of viral particles, but, by using colorimetric analysis techniques, the researchers could even effectively quantify the number of virus particles present in different areas of a sample depending on the color of the light reflected locally. The overall simplicity of the design is one of the main selling points of GTIP. Given that optical microscopes are available in most laboratories, the method developed by the group could become a valuable and ubiquitous diagnostic and virus research tool. Furthermore, GTIP is not limited to detecting viruses or strictly dependent on antibodies; any other binding agent works as well, helping visualize all kinds of particles that interact with light.

"Compared to existing COVID-19 diagnostic methods, our approach enables rapid detection and quantification of SARS-CoV-2 without needing extra sample treatments, such as amplification and labeling," explained Professor Young Min Song at GIST who led the research group. "Our strategy can even be applied for a dynamic monitoring of target particles sprayed in the air or dispersed on surfaces. We believe that this approach could be the basis for next-generation biosensing platforms, enabling simple yet accurate detection."

Related Links:
GIST 


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Serological Pipet Controller
PIPETBOY GENIUS
New
Host Response Immunoassay Test
MeMed BV
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.